Another bioinformatic analysis with the TCGA and GEO datasets suggests that CASKIN2 expression is significantly associated with a lower risk with Pancreatic adenocarcinoma (PAAD) [126]. This evidence concerns the gene CASKIN2 and pancreatic adenocarcinoma.